Desmopressin to improve safety after kidney biopsy
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older and able to give informed consent
- A kidney specialist must have already decided you need a kidney biopsy
- Your blood counts must be adequate (hemoglobin over 8 g/dL and platelets over 100,000)
- Your blood clotting tests must be normal (APTT and INR)
- Your blood pressure must be controlled (systolic under 160)
- No signs of body inflammation where the biopsy needle would enter
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
This trial tests if a drug called desmopressin can reduce the need for blood transfusions during heart surgery. It is for people at high risk of bleeding, for example because they take blood thinners, have a clotting problem, or need a repeat heart surgery.
This study tests whether a medicine called desmopressin (DDAVP) can reduce bleeding during heart surgery. It uses a special blood test (TEG6) to decide who gets the medicine.
This study tests a technique used during planned heart bypass surgery to see whether it changes substances measured in urine that reflect kidney stress or injury. If you have upcoming elective bypass surgery, your team may collect blood and urine samples to study how your kidneys respond.
Hear when a new Kidney Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.